Arabic AR Chinese (Simplified) ZH-CN English EN French FR German DE Japanese JA Portuguese PT Russian RU Spanish ES Ukrainian UK

Shkreli’s bros: Drug company raises everyday vitamin price by 800 percent

Latest news

    View the original article: https://www.rt.com/usa/412903-drug-company-vitamin-price-hike/?utm_source=rss&utm_medium=rss&utm_campaign=RSS

    Following the lead of pharma-bro Martin Shkreli, a US drug company has hiked the price of a prescription version of vitamin B3 pills by over 800 percent. A drug used to treat respiratory ailments also got a price hike of nearly 2,500 percent.

    Avondale Pharmaceuticals raised the price of Niacor, a prescription-only version of niacin (vitamin B3), by 809 percent last month. This means a bottle of 100 tablets went from costing $32.46 to $295, according to figures sent to the Financial Times.

    While the drug is available over the counter, some doctors prefer to prescribe a version that has US Food and Drug Administration approval. The drug is used to lower cholesterol to reduce the chance of having a heart attack.

    The company also acquired another generic, SSKI, and increased its price by 2,499 percent, taking a 30ml bottle from $11.48 to $295.

    The Birmingham, Alabama-based company raised its prices shortly after acquiring the rights to the drugs in a “buy-and-raise” deal made notorious by Martin Shkreli, the hedge fund investor recently convicted of securities fraud.

    Shkreli became mired in controversy when he raised the price of a drug used by cancer and HIV patients by 5,500 percent.

    Read more

    9 Big Pharma rip-offs 'worse than Martin Shkreli'

    The price hikes by Avondale were first noticed by Truven Health Analytics, according to The Independent.

    According to the Financial Times, Avondale Pharmaceuticals was set up in August by a registered agent, Acrogen Pharmaceuticals, seemingly for the sole purpose of drug acquisition. Acrogen was started in 2016 by Mark Pugh, an executive behind several pharmaceutical companies.

    “This is the latest example of an inefficient US market where the consumer, payer, and doctor don’t have all the information available to make a financially sound choice,” Michael Rae, CEO of Rx Savings, told FT. “They are caught in a web of inefficiency and are being taken advantage of.”

    Price gouging is a controversial but established strategy whereby firms buy up the rights to a drug that faces little or no competition, before massively inflating the price and enjoying the profits.

    In the same category are

    Beer Buzz: FIFA’s beer sponsor to sue 2018 World Cup stadium Football fans travelling to Russia’s Rostov for the 2018 World Cup this summer will not be left dry, as FIFA’s beer sponsor aims to sue city authoriti...
    US trying to create alternative govt in swathes of Syrian land – Lavrov on Afrin crisis The US is working to create alternative government systems on large parts of Syrian territory, which goes against its promises to respect the country’...
    ‘They look too poor to wear that’: Dutch police to ‘undress’ youths wearing clothes deemed fancy Rotterdam police are targeting youths wearing outfits that appear too fancy for them to afford, local media report. Authorities say the controversial ...
    Crowds gather for ‘March for Life’ demo in Washington (IMAGES) Thousands of anti-abortion advocates have descended on Washington DC for the annual March For Life demonstration at the National Mall. President Donal...
    ‘Offensive & painful’: Abuse victims slam pope over slander accusations Pope Francis has launched an astonishing attack on the victims of a pedophile priest, saying that those who publicly accused a bishop of covering up s...

    Leave a comment

    Your email address will not be published. Required fields are marked *